Our Monthly Meetings
PLEASE NOTE THAT THIS WEBSITE IS CURRENTLY BEING UPDATED AND SOME LINKS MAY NOT WORK.
If you are looking for information from the International Myeloma Foundation, please go directly to that site at http://myeloma.org/Main.action.
We meet on most third Tuesdays of the month from 6:00 – 8:00 PM at the Harold Leever Regional Cancer Center, 1075 Chase Parkway, Waterbury, CT 06708.
Patients, caregivers and friends share their knowledge and experiences on treatments, coping with side effects, medical insurance, participation in clinical trials, new scientific and clinical research and provide mutual support and encouragement.
We also invite experts to join us and share their knowledge. Call, email or mail to get on our email/phone list so you can receive the meeting announcements. You can also view the details of our next support group meeting, get driving directions, etc. here on our web site.
Please join us for our next meeting :
February 16, 2010 - 3 Guest Speakers!
Rose-Ann Chrzanowski, Reiki Master will be at the February meeting to offer Reiki sessions to members. Book a mini session and experience the healing benefits of the deep relaxation of Reiki. Please contact Robin to book your time slot now with Rose-Ann ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ). Many of you will remember Rose-Ann from last year when she visited with us . . .
Mike LaFrank and Kevin Campbell from Genzyme will be attending our meeting and will be available to answer questions and provide materials on Genzyme’s product Mozobil (plerixafor injection). Mozobil is approved by the United States Food and Drug Administration (FDA) to be used with another agent granulocyte-colony stimulating factor (G-CSF), to mobilize hematopoietic stem cells into the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) or multiple myeloma (MM).
Mike and Kevin will generously provide us with pizza and drinks for this meeting!
Our Mission
Our mission is to be an ongoing resource for information, support, shared experiences and hope for persons with multiple myeloma, their family and friends.
Our focus is to reach out to the myeloma community and empower them through education, provide support, and let them know they are not alone. Education is key in the fight against myeloma. Although we are not medical professionals, we strive to provide the most current information in myeloma treatment, clinical trials, side effects, pain management and quality of life issues by our affiliation with the International Myeloma Foundation. Patients talk about things that doctors don't - like insurance, bills, assistance, work and how to go about life in general. Our shared experiences help each other!
Subscribe To Our eMail List
Click here to join our email mailing list on Yahoo! Groups. Through this list, you can receive monthly meeting reminders and other announcements.
Multiple Myeloma
Multiple myeloma is a cancer of the cells in the bone marrow that affects production of red cells, white cells and stem cells. More specifically, it is an uncontrolled growth of plasma cells which attack and destroy bone. It is the 2 nd largest of the blood cancers affecting an estimated 750,000 people worldwide; in industrialized countries it is growing in number and affecting increasingly younger people. Although there is no known cure, multiple myeloma is treatable and outcomes are constantly improving.
Join us as we our share experiences and information with each other. Statistics show that people that attend support groups do better!
International Myeloma Foundation and Harold Leever Regional Cancer Center Acknowledgement
Latest Myeloma Research
The IMF produces webcasts from the major myeloma scientfic meetings. Recent webcasts available:
2009 American Society of Hematology (ASH) meetings held in New Orleans in December, 2009
Website Support/Host
The Connecticut Multiple Myeloma Fighter's Information Group website is supported and hosted by the International Myeloma Foundation.